FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:2475-2477 June 4, 2009 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Emslie, G. J. Related Article by Walkup, J. T. PubMed Citation

To the Editor: Walkup and colleagues (Dec. 25 issue)¹ conclude that the three active therapies they studied — a combination of cognitive behavioral therapy and sertraline, cognitive behavioral therapy alone, and sertraline alone — were effective treatment for anxiety in children, as compared with placebo. The authors further conclude that combination treatment had a superior response rate, as compared with active treatment alone. However, the study design invites questions. There was no treatment group in which cognitive behavioral therapy plus placebo was used. The absence of such a group prevented the investigators from determining whether the addition of sertraline to . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.